Showing results (801-810 of 1,190) with videos related to

Sort By:
Pageof 119
BMC Pharmacology & Toxicology|January 15, 2014
Hypersensitivity to oxaliplatin: clinical features and risk factorsMarie Parel, Florence Ranchon, Audrey Nosbaum, et al.
BMC Pharmacology & Toxicology|June 6, 2014
Conditional disruption of interactions between Gαi2 and regulator of G protein signaling (RGS) proteins protects the heart from ischemic injurySergio Parra, Xinyan Huang, Raelene A Charbeneau, et al.
BMC Pharmacology & Toxicology|June 25, 2014
Self-reported adverse drug reactions and their influence on highly active antiretroviral therapy in HIV infected patients: a cross sectional studyWondmagegn Tamiru Tadesse, Alemayehu Berhane Mekonnen, Wubshet Hailu Tesfaye, et al.
BMC Pharmacology & Toxicology|June 11, 2014
Medication errors related to transdermal opioid patches: lessons from a regional incident reporting systemHenrik Lövborg, Mikael Holmlund, Staffan Hägg
BMC Pharmacology & Toxicology|January 28, 2015
Interventions to decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin (5-HT3) receptor antagonists: a systematic reviewAndrea C Tricco, Charlene Soobiah, Wing Hui, et al.
BMC Pharmacology & Toxicology|July 8, 2020
Influence of strengthened hemoperfusion combined with continuous venovenous hemofiltration on prognosis of patients with acute paraquat poisoning: SHP + CVVH improve prognosis of acute PQ patientsAn-Bao Chen, Fang Li, E-Mu Di, et al.
BMC Pharmacology & Toxicology|July 2, 2020
Brown adipose tissue activity is modulated in olanzapine-treated young rats by simvastatinXuemei Liu, Xiyu Feng, Chao Deng, et al.
BMC Pharmacology & Toxicology|April 17, 2015
Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancerSandrina Lambrechts, Diether Lambrechts, Evelyn Despierre, et al.
BMC Pharmacology & Toxicology|July 10, 2020
Clinical efficacy and safety in patients treated with teicoplanin with a target trough concentration of 20 μg/mL using a regimen of 12 mg/kg for five doses within the initial 3 daysTakashi Ueda, Yoshio Takesue, Kazuhiko Nakajima, et al.
BMC Pharmacology & Toxicology|September 27, 2018
Using superparamagnetic iron oxide nanoparticles to enhance bioavailability of quercetin in the intact rat brainRezvan Enteshari Najafabadi, Nasrin Kazemipour, Abolghasem Esmaeili, et al.
Pageof 119